Byline: Olivia Dimmer
-
‘Hidden’ Irregular Heartbeats May Raise Risk of Death
Irregular heartbeats can raise a person’s risk of death even when they go unnoticed by traditional heart monitoring, according to a Northwestern Medicine study published in Circulation.
-
Analyzing the Effects of Dietary Acculturation on Heart Health
Dietary acculturation may increase the risk of heart disease for people of Hispanic or Latino heritage in the U.S., according to a study published in Circulation.
-
Building Strong Student Communities at Feinberg
Catch up with Eli Zimmerman, MD, the new associate dean for student affairs, who has settled into his role since joining Feinberg at the start of this year.
-
First-Year Medical Students Celebrate New Academic Year at Founders’ Day
First-year medical students donned their white coats for the first time and marked the official start to the academic year at Founders’ Day on August 2 at Fourth Presbyterian Church in Chicago.
-
Summer Research Program Trains Future Clinician-Scientists
Eight Feinberg medical students recently participated in a summerlong research program designed to equip them with the skills to become successful clinician-scientists.
-
Developing New Methods for Targeted Protein Degradation
Northwestern Medicine scientists have developed a new, more precise method to target proteins implicated in certain types of cancer, according to a study published in Nature Chemical Biology.
-
Understanding Molecular Drivers of Lymphedema
Northwestern Medicine scientists have uncovered molecular mechanisms underlying lymphatic valve development, a discovery which could prove useful in treating lymphedema, according to a study published in The Journal of Clinical Investigation.
-
Exploring CAR T-cell Therapy for Aggressive Follicular Lymphoma
CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine.
-
Understanding the Role of RNA Methylation in Cancer
RNA modifications could serve as a therapeutic target for certain types of cancer, according to a new study published in Molecular Cell which sheds new light on the complex process underlying RNA transcription.
-
Remembering Pioneering Pharmacologist V. Craig Jordan
V. Craig Jordan, PhD, the groundbreaking pharmacologist known as the “father” of breast cancer drug Tamoxifen, has died at 76.
